CDK4 and breast cancer: The CDK4/6-RB axis is critical for cell cycle entry and not surprisingly most cancers subvert this axis to promote proliferation; for instance, 19% of BC show amplification of CDK4 and CCND1 amplification is associated with endocrine resistance (reviewed by [33]).